AZ Oral GLP-1 Shows Competitive Phase 2 Efficacy
09 Jun 2026 //
FIERCE BIOTECH
AstraZeneca unveils data behind Phase III-bound oral GLP-1
08 Jun 2026 //
PRESS RELEASE
Elecoglipron Clinical Data to Be Presented at ADA 2026
01 Jun 2026 //
BUSINESSWIRE
09 Jun 2026 //
FIERCE BIOTECH
08 Jun 2026 //
PRESS RELEASE
01 Jun 2026 //
BUSINESSWIRE
Market Place
Sourcing Support